Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Graphite Bio, Inc. ("Graphite" or the "Company") (NASDAQ: GRPH). Such investors...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Graphite Bio, Inc. ("Graphite" or the "Company") (NASDAQ: GRPH). Such investors...
Graphite Bio (NASDAQ:GRPH – Get Rating) had its price objective dropped by stock analysts at SVB Leerink from $34.00 to $18.00 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm presently has an “outperform” rating on the stock. SVB Leerink’s target price would suggest a potential upside of 219.72% from the stock’s […]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.